On the Record · Jazz Pharmaceuticals
Jazz Pharmaceuticals subsidiaries, as it lists them
The subsidiaries Jazz Pharmaceuticals lists in its latest annual report, with the jurisdiction of each, linked to the filing.
Subsidiaries it lists
| Subsidiary | Jurisdiction |
|---|---|
| Jazz Pharmaceuticals Ireland Limited | Ireland |
| Jazz Financing I DAC | Ireland |
| Jazz Pharmaceuticals Operations UK Limited | United Kingdom |
| Jazz Pharmaceuticals, Inc. | Delaware |
| Jazz Pharmaceuticals Therapeutics, Inc. | Delaware |
| Jazz Pharmaceuticals Research UK Limited | United Kingdom |
| Gentium S.r.l. | Italy |
| Jazz Pharmaceuticals UK Holdings Limited | United Kingdom |
| Jazz Securities DAC | Ireland |
| Jazz Financing Holdings Limited | Ireland |
| Jazz Financing Lux S.à.r.l | Luxembourg |
| Jazz Pharmaceuticals International Limited | Ireland |
| Jazz Investments Europe Limited | Malta |
| Jazz Capital Limited | Ireland |
| Jazz Pharmaceuticals UK Limited | United Kingdom |
| GW Pharmaceuticals Limited | United Kingdom |
| Chimerix, Inc. | Delaware |
| Jazz Investments I Limited | Bermuda |
From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.
Read from Jazz Pharmaceuticals’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.